Skip to main content
. 2020 Oct 19;11:584251. doi: 10.3389/fmicb.2020.584251

FIGURE 3.

FIGURE 3

(A) Evolution of the NAb titer in 30 COVID-19 inpatients during the first month post-symptom onset. (B) Evolution of the NAb titer in 11 COVID-19 inpatients after more than 40 days post-symptom onset. The dashed line indicates the cut-off of the assay. (C–F) Correlations between NAb titers and anti-S1 (C), anti-S2 (D), anti-RBD (E), and anti-N (F) antibody levels. Dashed lines indicate assay cut-offs for positivity. OD, optical density.